A new partnership will bring three new medications to the Middle East and North Africa, including an Ocrevus biosimilar drug ...

The FDA gave Hope Bioscience's stem cell therapy RMAT designation after clinical data suggested it may improve life for ...

Most children with MS have chronic lesions that slowly get bigger over time, but their frequency doesn't correlate with ...

Most MS neurologists in the US have received physician pharma payments, and a study suggests this may influence their ...

Civicascript said its low-cost generic version of Ampyra is now available in the U.S., offering significant savings and ...

A study identified a protein that stalls myelin repair in the brain, suggesting that targeting it could be a strategy for MS treatment.

Columnist Ben Hofmeister, who didn't really have a wish list of must-do activities before his MS diagnosis, shares his "MS bucket list." ...

A new artificial intelligence model suggests that MS should be classified along a single disease continuum rather than into ...

Columnist Leigh Anne Nelson describes the odd itching sensation she experiences due to MS, which occurs randomly and suddenly.

Columnist Ben Hofmeister knows what it's like to grieve his multiple sclerosis and has learned what well-meaning words not to say.

After 14 reported cases, Health Canada is warning that glatiramer acetate products for MS can cause anaphylaxis, a severe allergic reaction.

The UAE became the first country to approve tolebrutinib, making it available to adults with nonrelapsing secondary progressive MS.